Re; Singh S, Patil S, Tamhankar AS, Ahluwalia P, Gautam G. Low-risk prostate cancer in India: Is active surveillance a valid treatment option? Indian J Urol 2020;36:184-90

Detalles Bibliográficos
Autores principales: Pandey, Abhishek, Mandal, Swarnendu, Das, Manoj K., Nayak, Prasant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Letters to Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759172/
https://www.ncbi.nlm.nih.gov/pubmed/33376278
http://dx.doi.org/10.4103/iju.IJU_389_20
_version_ 1783627075141238784
author Pandey, Abhishek
Mandal, Swarnendu
Das, Manoj K.
Nayak, Prasant
author_facet Pandey, Abhishek
Mandal, Swarnendu
Das, Manoj K.
Nayak, Prasant
author_sort Pandey, Abhishek
collection PubMed
description
format Online
Article
Text
id pubmed-7759172
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-77591722020-12-28 Re; Singh S, Patil S, Tamhankar AS, Ahluwalia P, Gautam G. Low-risk prostate cancer in India: Is active surveillance a valid treatment option? Indian J Urol 2020;36:184-90 Pandey, Abhishek Mandal, Swarnendu Das, Manoj K. Nayak, Prasant Indian J Urol Letters to Editor Wolters Kluwer - Medknow 2020 2020-10-01 /pmc/articles/PMC7759172/ /pubmed/33376278 http://dx.doi.org/10.4103/iju.IJU_389_20 Text en Copyright: © 2020 Indian Journal of Urology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Letters to Editor
Pandey, Abhishek
Mandal, Swarnendu
Das, Manoj K.
Nayak, Prasant
Re; Singh S, Patil S, Tamhankar AS, Ahluwalia P, Gautam G. Low-risk prostate cancer in India: Is active surveillance a valid treatment option? Indian J Urol 2020;36:184-90
title Re; Singh S, Patil S, Tamhankar AS, Ahluwalia P, Gautam G. Low-risk prostate cancer in India: Is active surveillance a valid treatment option? Indian J Urol 2020;36:184-90
title_full Re; Singh S, Patil S, Tamhankar AS, Ahluwalia P, Gautam G. Low-risk prostate cancer in India: Is active surveillance a valid treatment option? Indian J Urol 2020;36:184-90
title_fullStr Re; Singh S, Patil S, Tamhankar AS, Ahluwalia P, Gautam G. Low-risk prostate cancer in India: Is active surveillance a valid treatment option? Indian J Urol 2020;36:184-90
title_full_unstemmed Re; Singh S, Patil S, Tamhankar AS, Ahluwalia P, Gautam G. Low-risk prostate cancer in India: Is active surveillance a valid treatment option? Indian J Urol 2020;36:184-90
title_short Re; Singh S, Patil S, Tamhankar AS, Ahluwalia P, Gautam G. Low-risk prostate cancer in India: Is active surveillance a valid treatment option? Indian J Urol 2020;36:184-90
title_sort re; singh s, patil s, tamhankar as, ahluwalia p, gautam g. low-risk prostate cancer in india: is active surveillance a valid treatment option? indian j urol 2020;36:184-90
topic Letters to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759172/
https://www.ncbi.nlm.nih.gov/pubmed/33376278
http://dx.doi.org/10.4103/iju.IJU_389_20
work_keys_str_mv AT pandeyabhishek resinghspatilstamhankarasahluwaliapgautamglowriskprostatecancerinindiaisactivesurveillanceavalidtreatmentoptionindianjurol20203618490
AT mandalswarnendu resinghspatilstamhankarasahluwaliapgautamglowriskprostatecancerinindiaisactivesurveillanceavalidtreatmentoptionindianjurol20203618490
AT dasmanojk resinghspatilstamhankarasahluwaliapgautamglowriskprostatecancerinindiaisactivesurveillanceavalidtreatmentoptionindianjurol20203618490
AT nayakprasant resinghspatilstamhankarasahluwaliapgautamglowriskprostatecancerinindiaisactivesurveillanceavalidtreatmentoptionindianjurol20203618490

Ejemplares similares